Morgan Stanley’s Evolus EOLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.65M | Sell |
237,559
-2,574
| -1% | -$15.2K | ﹤0.01% | 4951 |
|
|
2026
Q1 | $987K | Sell |
240,133
-490,532
| -67% | -$2.38M | ﹤0.01% | 5146 |
|
|
2025
Q4 | $4.86M | Buy |
730,665
+464,937
| +175% | +$3.15M | ﹤0.01% | 4194 |
|
|
2025
Q3 | $1.63M | Sell |
265,728
-695,425
| -72% | -$5.42M | ﹤0.01% | 4905 |
|
|
2025
Q2 | $8.85M | Buy |
961,153
+122,011
| +15% | +$1.25M | ﹤0.01% | 3547 |
|
|
2025
Q1 | $10.1M | Buy |
839,142
+33,902
| +4% | +$443K | ﹤0.01% | 3333 |
|
|
2024
Q4 | $8.89M | Sell |
805,240
-195,309
| -20% | -$2.75M | ﹤0.01% | 3505 |
|
|
2024
Q3 | $16.2M | Sell |
1,000,549
-480,164
| -32% | -$6.71M | ﹤0.01% | 3002 |
|
|
2024
Q2 | $16.1M | Sell |
1,480,713
-1,562,090
| -51% | -$19.2M | ﹤0.01% | 2902 |
|
|
2024
Q1 | $42.6M | Buy |
3,042,803
+460,092
| +18% | +$5.98M | ﹤0.01% | 1904 |
|
|
2023
Q4 | $27.2M | Buy |
2,582,711
+2,056,136
| +390% | +$18.4M | ﹤0.01% | 2357 |
|
|
2023
Q3 | $4.81M | Buy |
526,575
+273,426
| +108% | +$2.45M | ﹤0.01% | 3771 |
|
|
2023
Q2 | $1.84M | Buy |
253,149
+138,885
| +122% | +$1.2M | ﹤0.01% | 4483 |
|
|
2023
Q1 | $967K | Buy |
114,264
+54,639
| +92% | +$494K | ﹤0.01% | 4884 |
|
|
2022
Q4 | $448K | Sell |
59,625
-3,375
| -5% | -$26.1K | ﹤0.01% | 5301 |
|
|
2022
Q3 | $507K | Sell |
63,000
-118,186
| -65% | -$1.25M | ﹤0.01% | 5261 |
|
|
2022
Q2 | $2.1M | Buy |
181,186
+129,570
| +251% | +$1.53M | ﹤0.01% | 4498 |
|
|
2022
Q1 | $579K | Sell |
51,616
-15,060
| -23% | -$128K | ﹤0.01% | 5320 |
|
|
2021
Q4 | $434K | Sell |
66,676
-144,581
| -68% | -$992K | ﹤0.01% | 5630 |
|
|
2021
Q3 | $1.61M | Buy |
211,257
+24,449
| +13% | +$253K | ﹤0.01% | 4740 |
|
|
2021
Q2 | $2.36M | Buy |
186,808
+32,719
| +21% | +$360K | ﹤0.01% | 4506 |
|
|
2021
Q1 | $2M | Buy |
154,089
+68,588
| +80% | +$632K | ﹤0.01% | 4256 |
|
|
2020
Q4 | $287K | Sell |
85,501
-62,422
| -42% | -$234K | ﹤0.01% | 5398 |
|
|
2020
Q3 | $578K | Sell |
147,923
-71,413
| -33% | -$261K | ﹤0.01% | 4563 |
|
|
2020
Q2 | $1.16M | Sell |
219,336
-10,125
| -4% | -$46.6K | ﹤0.01% | 4055 |
|
|
2020
Q1 | $952K | Buy |
229,461
+95,502
| +71% | +$809K | ﹤0.01% | 3994 |
|
|
2019
Q4 | $1.63M | Sell |
133,959
-6,662
| -5% | -$93.9K | ﹤0.01% | 4195 |
|
|
2019
Q3 | $2.2M | Buy |
140,621
+3,421
| +2% | +$56.1K | ﹤0.01% | 3691 |
|
|
2019
Q2 | $2.01M | Sell |
137,200
-64,508
| -32% | -$1.28M | ﹤0.01% | 3767 |
|
|
2019
Q1 | $4.55M | Buy |
201,708
+142,351
| +240% | +$3.08M | ﹤0.01% | 2802 |
|
|
2018
Q4 | $707K | Buy |
59,357
+13,461
| +29% | +$192K | ﹤0.01% | 4557 |
|
|
2018
Q3 | $855K | Sell |
45,896
-147,655
| -76% | -$3.2M | ﹤0.01% | 4662 |
|
|
2018
Q2 | $5.42M | Buy |
193,551
+177,161
| +1,081% | +$3.13M | ﹤0.01% | 3059 |
|
|
2018
Q1 | $148K | Buy |
+16,390
| New | +$188K | ﹤0.01% | 5589 |
|
Other funds holding EOLS
NCM
B
FLSM
PA
SCM
Morgan Stanley's EOLS Position: Q2 2026 in Review
Morgan Stanley reduced its Evolus (EOLS) stake by 1.1% in Q2 2026, selling an estimated $15.2K and leaving 237,559 shares worth $1.65M. The position accounts for ﹤0.01% of the portfolio, ranked #4951.
Morgan Stanley first reported a position in EOLS in Q1 2018 and has held it in 34 quarters since. The position peaked at $42.6M in Q1 2024. 158 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.
- Morgan Stanley held 237,559 shares of Evolus worth $1.65M as of Q2 2026.
- Morgan Stanley sold 2,574 Evolus shares in Q2 2026, an estimated $15.2K.
- Evolus made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #4951 holding.
- Morgan Stanley first reported a position in Evolus in Q1 2018 and has held it in 34 quarters since.
- Morgan Stanley's Evolus position peaked at $42.6M in Q1 2024.
- 158 funds tracked by Wall St. Rank held Evolus as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.